Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells

被引:35
|
作者
Babbio, Federica [1 ]
Castiglioni, Ilaria [1 ]
Cassina, Chiara [1 ]
Gariboldi, Marzia Bruna [1 ]
Pistore, Christian [1 ]
Magnani, Elena [1 ]
Badaracco, Gianfranco [2 ]
Monti, Elena [1 ]
Bonapace, Ian Marc [1 ]
机构
[1] Insubria Univ, Dept Theoret & Appl Sci, I-21052 Busto Arsizio, Italy
[2] Insubria Univ, Dept Biotechnol & Life Sci, I-21100 Varese, Italy
来源
BMC CELL BIOLOGY | 2012年 / 13卷
关键词
Methyl CpG-binding protein 2 (MeCP2); Cell proliferation; Nuclear lamins; GILFORD-PROGERIA-SYNDROME; PROSTATE-CANCER CELLS; DNA METHYLATION; RETT-SYNDROME; B RECEPTOR; DYNAMIC PROPERTIES; ENVELOPE; SENESCENCE; APOPTOSIS; MITOSIS;
D O I
10.1186/1471-2121-13-19
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: MeCP2 (CpG-binding protein 2) is a nuclear multifunctional protein involved in several cellular processes, like large-scale chromatin reorganization and architecture, and transcriptional regulation. In recent years, a non-neuronal role for MeCP2 has emerged in cell growth and proliferation. Mutations in the MeCP2 gene have been reported to determine growth disadvantages in cultured lymphocyte cells, and its functional ablation suppresses cell growth in glial cells and proliferation in mesenchymal stem cells and prostate cancer cells. MeCP2 interacts with lamin B receptor (LBR) and with Heterochromatin Protein 1 (HP1) at the nuclear envelope (NE), suggesting that it could be part of complexes involved in attracting heterochromatin at the nuclear periphery and in mediating gene silencing. The nuclear lamins, major components of the lamina, have a role in maintaining NE integrity, in orchestrating mitosis, in DNA replication and transcription, in regulation of mitosis and apoptosis and in providing anchoring sites for chromatin domains. In this work, we inferred that MeCP2 might have a role in nuclear envelope stability, thereby affecting the proliferation pattern of highly proliferating systems. Results: By performing knock-down (KD) of MeCP2 in normal murine (NIH-3 T3) and in human prostate transformed cells (PC-3 and LNCaP), we observed a strong proliferation decrease and a defect in the cell cycle progression, with accumulation of cells in S/G(2)M, without triggering a strong apoptotic and senescent phenotype. In these cells, KD of MeCP2 evidenced a considerable decrease of the levels of lamin A, lamin C, lamin B1 and LBR proteins. Moreover, by confocal analysis we confirmed the reduction of lamin A levels, but we also observed an alteration in the shape of the nuclear lamina and an irregular nuclear rim. Conclusions: Our results that indicate reduced levels of NE components, are consistent with a hypothesis that the deficiency of MeCP2 might cause the lack of a key "bridge" function that links the peripheral heterochromatin to the NE, thereby causing an incorrect assembly of the NE itself, together with a decreased cell proliferation and viability.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells
    Federica Babbio
    Ilaria Castiglioni
    Chiara Cassina
    Marzia Bruna Gariboldi
    Christian Pistore
    Elena Magnani
    Gianfranco Badaracco
    Elena Monti
    Ian Marc Bonapace
    BMC Cell Biology, 13
  • [2] Mutations and polymorphisms in the human methyl CpG-binding protein MECP2
    Miltenberger-Miltenyi, G
    Laccone, F
    HUMAN MUTATION, 2003, 22 (02) : 107 - 115
  • [3] Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2)
    Tanaka, Yoshiaki
    Kim, Kun-Yong
    Zhong, Mei
    Pan, Xinghua
    Weissman, Sherman Morton
    Park, In-Hyun
    HUMAN MOLECULAR GENETICS, 2014, 23 (04) : 1045 - 1055
  • [4] The Chromatin-binding Protein HMGN1 Regulates the Expression of Methyl CpG-binding Protein 2 (MECP2) and Affects the Behavior of Mice
    Abuhatzira, Liron
    Shamir, Alon
    Schones, Dustin E.
    Schaeffer, Alejandro A.
    Bustin, Michael
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (49) : 42051 - 42062
  • [5] Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver
    Esfandiari, F
    Green, R
    Cotterman, RF
    Pogribny, IP
    James, SJ
    Miller, JW
    CARCINOGENESIS, 2003, 24 (12) : 1935 - 1940
  • [6] Biological function of the methyl-CpG binding protein MeCP2
    Bird, A
    Guy, J
    Hendrich, B
    Free, A
    Ng, HH
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S15 - S15
  • [7] The methyl-CpG-binding protein MeCP2 and neurological disease
    Bird, Adrian
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 575 - 583
  • [8] Expression of methyl CpG binding protein 2 (Mecp2) during the postnatal development of the mouse brainstem
    Dura, Ernmanuelle
    Villard, Laurent
    Roux, Jean-Christophe
    BRAIN RESEARCH, 2008, 1236 : 176 - 184
  • [9] Reduced methyl-CpG-binding protein 2 (MeCP2) in methyl deficient rat liver associated with altered expression of MeCP2 mRNA splice variants
    Esfandiari, F
    Cotterman, RF
    Green, R
    Miller, JW
    FASEB JOURNAL, 2003, 17 (04): : A672 - A672
  • [10] The methyl-CpG- binding protein MECP2 is required for prostate cancer cell growth
    Bernard, D
    Gil, J
    Dumont, P
    Rizzo, S
    Monté, D
    Quatannens, B
    Hudson, D
    Visakorpi, T
    Fuks, F
    de Launoit, Y
    ONCOGENE, 2006, 25 (09) : 1358 - 1366